CME Group Inc. $CME Stock: Composition Wealth LLC Grows Stake

Composition Wealth LLC lifted its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 70.1% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 13,526 shares of the financial services provider’s stock after buying an additional 5,573 shares during the period. Composition Wealth LLC’s holdings in CME Group were worth $3,543,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of CME. Voya Investment Management LLC grew its stake in CME Group by 515.8% during the third quarter. Voya Investment Management LLC now owns 766,090 shares of the financial services provider’s stock worth $200,522,000 after buying an additional 641,679 shares in the last quarter. Bogart Wealth LLC lifted its holdings in shares of CME Group by 1.5% during the 3rd quarter. Bogart Wealth LLC now owns 75,564 shares of the financial services provider’s stock worth $19,796,000 after acquiring an additional 1,148 shares during the period. Public Sector Pension Investment Board lifted its holdings in shares of CME Group by 16.8% during the 3rd quarter. Public Sector Pension Investment Board now owns 215,185 shares of the financial services provider’s stock worth $59,937,000 after acquiring an additional 31,014 shares during the period. Global Retirement Partners LLC boosted its position in shares of CME Group by 3.3% during the 3rd quarter. Global Retirement Partners LLC now owns 10,902 shares of the financial services provider’s stock worth $2,856,000 after acquiring an additional 344 shares in the last quarter. Finally, South Dakota Investment Council increased its stake in CME Group by 27.3% in the third quarter. South Dakota Investment Council now owns 6,157 shares of the financial services provider’s stock valued at $1,613,000 after acquiring an additional 1,319 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

More CME Group News

These are some of the CME news items that stood out recently:

  • Neutral Sentiment: CEO Terrence Duffy discussed CME Group’s Tour Championship and prediction markets in a media interview, but the coverage provided no specific financial or business update. Article
  • Negative Sentiment: Duffy sold 27,000 shares for about $8.36 million, reducing his direct stake by 43.24%. General Counsel John Clifford Marchese also sold 655 shares, an 18.20% reduction in his holdings. Insider sales can be made for personal reasons and do not necessarily signal a change in company outlook, but the CEO’s sale may weigh on sentiment. CEO filing General counsel filing
  • Negative Sentiment: A valuation-focused report says CME shares may be fully valued after a 69% run, raising the risk that expectations are already reflected in the price. Article

Insider Buying and Selling

In related news, General Counsel John Clifford Marchese sold 655 shares of the firm’s stock in a transaction that occurred on Wednesday, November 18th. The shares were sold at an average price of $310.75, for a total value of $203,541.25. Following the completion of the transaction, the general counsel owned 2,943 shares in the company, valued at $914,537.25. This trade represents a 18.20% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Sunil Cutinho sold 5,000 shares of CME Group stock in a transaction that occurred on Tuesday, October 27th. The stock was sold at an average price of $298.70, for a total transaction of $1,493,500.00. Following the sale, the insider owned 20,037 shares in the company, valued at approximately $5,985,051.90. This represents a 19.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 61,166 shares of company stock valued at $18,276,512 over the last three months. Insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several brokerages have commented on CME. Wells Fargo & Company boosted their price objective on shares of CME Group from $315.00 to $333.00 and gave the company an “overweight” rating in a research report on Thursday, October 22nd. Deutsche Bank lowered CME Group from a “buy” rating to a “hold” rating and decreased their price target for the company from $286.00 to $270.00 in a research note on Wednesday, August 19th. Weiss Ratings raised CME Group from a “buy (b)” rating to a “buy (b+)” rating in a report on Friday, November 13th. Barclays upped their price objective on CME Group from $281.00 to $321.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 22nd. Finally, Bank of America raised their price objective on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research note on Thursday, July 23rd. Ten equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $314.44.

View Our Latest Stock Analysis on CME

CME Group Trading Down 1.3%

NASDAQ CME opened at $306.31 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company has a market cap of $109.64 billion, a price-to-earnings ratio of 25.13, a price-to-earnings-growth ratio of 3.79 and a beta of 0.15. The business’s fifty day moving average is $288.79 and its 200 day moving average is $282.00.

CME Group (NASDAQ:CME – Get Free Report) last issued its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.99 by $0.03. The business had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.71 billion. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The business’s revenue for the quarter was up 10.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.68 EPS. As a group, sell-side analysts expect that CME Group Inc. will post 12.35 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 11th will be issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Friday, December 11th. CME Group’s payout ratio is 42.66%.

CME Group Company Profile

(Free Report)

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.